entertainment -WSS

entertainment

author：explore 2025-09-06 08:25:06 - browse：687

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Menendez indictment could see pharma lose a key ally

leisure time

WSS

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Paxlovid should be available without a positive Covid test

Why do women spend more than men on medical expenses?

ASCO: Palliative care found as helpful given virtually as in person

Kaiser Permanente unions announce official strike date

Kaiser Permanente unions announce official strike date

knowledge

entertainment

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Biogen shutters digital health group, ends Apple study, in cost cutting move

Anesthesiologist group: stop taking Ozempic before surgery

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Medicare details structure of new drug price negotiation program

Ionis has late

Affirmative action in medical school literally saved lives

See how much Covid

ChatGPT in medicine: STAT answers readers' burning questions

Kaiser Permanente unions announce official strike date

explore

How to increase colonoscopy rates? Looks like an AI can help

STAT Virtual Event: How to Increase Diversity in Clinical Trials

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Biogen shutters digital health group, ends Apple study, in cost cutting move

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

With trial win, GSK could get blood cancer drug back on market

knowledge

knowledge

leisure time

hotspot